Aramark (ARMK) director adds shares via dividend equivalent rights

Rhea-AI Filing Summary

Aramark director reports additional stock from dividend equivalents. A director of Aramark reported receiving 255.993 shares of common stock on 12/17/2025, credited as dividend equivalent rights on deferred stock units. These rights arose from the company’s quarterly dividend and vest on the same schedule as the underlying deferred stock awards. Following this transaction, the director beneficially owns 94,298.114 Aramark common shares directly and 15,000 shares indirectly through a trust. The shares in this filing were acquired at a stated price of $0, reflecting a non-cash adjustment tied to existing compensation rather than an open-market purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SADOVE STEPHEN I

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		255.993(1)	A	$0	94,298.114	D
Common Stock								15,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report on December 17, 2025?

An Aramark director reported acquiring 255.993 shares of common stock on 12/17/2025 as dividend equivalent rights tied to deferred stock units.

What are the dividend equivalent rights reported in this Aramark (ARMK) Form 4?

The filing states the dividend equivalent rights accrued from Aramark’s quarterly dividend on deferred stock units and vest on the same schedules as the underlying awards.

How many Aramark (ARMK) shares does the reporting person own after this transaction?

After the reported transaction, the director beneficially owns 94,298.114 Aramark common shares directly and 15,000 shares indirectly through a trust.

Was any cash paid for the Aramark (ARMK) shares acquired in this Form 4?

No cash was paid for these shares; the 255.993 shares of common stock were acquired at a reported price of $0 as a result of dividend equivalent rights.

What is the relationship of the reporting person to Aramark (ARMK)?

The reporting person is identified as a Director of Aramark, according to the relationship section of the filing.

How are the indirect Aramark (ARMK) holdings of the reporting person structured?

The Form 4 notes that 15,000 Aramark common shares are held indirectly by the reporting person through a trust.